To include your compound in the COVID-19 Resource Center, submit it here.

Emergent gains on anthrax vaccine contract

Emergent BioSolutions Inc. (NYSE:EBS) jumped $3.33 (16%) to

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE